A carregar...
Antibodies to watch in 2014
Since 2010, mAbs has documented the biopharmaceutical industry’s progress in transitioning antibody therapeutics to first Phase 3 clinical studies and regulatory review, and its success at gaining first marketing approvals for antibody-based products. This installment of the “Antibodies to watch” se...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Landes Bioscience
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3929455/ https://ncbi.nlm.nih.gov/pubmed/24284914 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.27333 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|